First Mercantile Trust’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $73K | Buy |
721
+123
| +21% | +$12.5K | 0.01% | 727 |
|
|
2021
Q2 | $85K | Sell |
598
-62
| -9% | -$8.81K | 0.01% | 728 |
|
|
2021
Q1 | $66K | Buy |
660
+190
| +40% | +$19K | 0.01% | 754 |
|
|
2020
Q4 | $58K | Sell |
470
-39
| -8% | -$4.81K | 0.01% | 774 |
|
|
2020
Q3 | $89K | Hold |
509
| – | – | 0.01% | 706 |
|
|
2020
Q2 | $79K | Sell |
509
-1,036
| -67% | -$161K | 0.01% | 733 |
|
|
2020
Q1 | $223K | Sell |
1,545
-68
| -4% | -$9.82K | 0.03% | 310 |
|
|
2019
Q4 | $330K | Buy |
1,613
+415
| +35% | +$84.9K | 0.04% | 311 |
|
|
2019
Q3 | $96K | Sell |
1,198
-2
| -0.2% | -$160 | 0.01% | 704 |
|
|
2019
Q2 | $113K | Sell |
1,200
-136
| -10% | -$12.8K | 0.01% | 604 |
|
|
2019
Q1 | $114K | Sell |
1,336
-60
| -4% | -$5.12K | 0.03% | 625 |
|
|
2018
Q4 | $78K | Sell |
1,396
-652
| -32% | -$36.4K | 0.02% | 712 |
|
|
2018
Q3 | $167K | Buy |
+2,048
| New | +$167K | 0.03% | 566 |
|